ZURAWSKI; Sandra

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZURAWSKI; Sandra.The latest application filed is for "recombinant proteins with cd40 activating properties".

Company Profile

16.34.39

ZURAWSKI; Sandra - Midlotian TX
Zurawski; Sandra - Midlothian TX
Zurawski; Sandra - San Juan Bautista CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant Proteins With Cd40 Activating Properties App 20220175920 - LEVY; Yves ; et al.	2022-06-09
Nucleic acids encoding anti-CD40 antibodies Grant 11,267,895 - Banchereau , et al. March 8, 2	2022-03-08
Methods and compositions for treating and preventing HIV Grant 11,219,683 - Levy , et al. January 11, 2	2022-01-11
Fusion Proteins Comprising An Anti-cd40 Antibody And Cancer Antigens App 20210308242 - ZURAWSKI; Gerard ; et al.	2021-10-07
Methods and Compositions for Treating Autoimmune and Inflammatory Conditions App 20210299224 - OH; SangKon ; et al.	2021-09-30
Novel Vaccines Against Hpv And Hpv-related Diseases App 20210268097 - OH; SangKon ; et al.	2021-09-02
Methods and compositions for treating autoimmune and inflammatory conditions Grant 10,993,990 - Oh , et al. May 4, 2	2021-05-04
Fusion proteins comprising an anti-CD40 antibody and cancer antigens Grant 10,980,869 - Zurawski , et al. April 20, 2	2021-04-20
Vaccines against HPV and HPV-related diseases Grant 10,940,195 - Oh , et al. March 9, 2	2021-03-09
Anti-cd40 Antibodies And Uses Thereof App 20210024641 - Banchereau; Jacques F. ; et al.	2021-01-28
Methods And Compositions For Treating And Preventing Hiv App 20200316191 - LEVY; Yves ; et al.	2020-10-08
Methods and compositions for treating and preventing HIV Grant 10,722,572 - Levy , et al.	2020-07-28
Anti-CD40 antibodies Grant 10,683,361 - Banchereau , et al.	2020-06-16
Methods and compositions for treating and preventing HIV Grant 10,610,585 - Levy , et al.	2020-04-07
Methods And Compositions For Treating And Preventing Hiv App 20200101152 - LEVY; Yves ; et al.	2020-04-02
Antagonistic anti-OX40L antibodies and methods of their use Grant 10,570,208 - Liu , et al. Feb	2020-02-25
Novel Vaccines Against Hpv And Hpv-related Diseases App 20190314481 - OH; SangKon ; et al.	2019-10-17
Methods and Compositions for Treating and Preventing HIV App 20190184008 - Levy; Yves ; et al.	2019-06-20
Vaccines against HPV and HPV-related diseases Grant 10,286,058 - Oh , et al.	2019-05-14
Antagonistic Anti-ox40l Antibodies And Methods Of Their Use App 20190092869 - Liu; Yong-Jun ; et al.	2019-03-28
Anti-cd40 Antibodies And Uses Thereof App 20190085088 - Banchereau; Jacques F. ; et al.	2019-03-21
Antagonistic anti-OX40L antibodies and methods of their use Grant 10,167,339 - Liu , et al. J	2019-01-01
Method of making an anti-CD40 antibody Grant 10,087,256 - Banchereau , et al. October 2, 2	2018-10-02
Antigen Presenting Cell Targeted Cancer Vaccines App 20180000916 - Zurawski; Gerard ; et al.	2018-01-04
Antagonistic Anti-ox40l Antibodies And Methods Of Their Use App 20170349661 - LIU; Yong-Jun ; et al.	2017-12-07
Anti-cd40 Antibodies And Uses Thereof App 20170114142 - Banchereau; Jacques F. ; et al.	2017-04-27
Methods and Compositions for Treating Autoimmune and Inflammatory Conditions App 20170106051 - Oh; SangKon ; et al.	2017-04-20
Anti-CD40 antibodies Grant 9,567,401 - Banchereau , et al. February 14, 2	2017-02-14
Anti-CD40 antibodies Grant 9,562,104 - Banchereau , et al. February 7, 2	2017-02-07
Novel Vaccines Against Hpv And Hpv-related Diseases App 20160331825 - OH; SangKon ; et al.	2016-11-17
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Grant 9,339,556 - Banchereau , et al. May 17, 2	2016-05-17
Vaccines directed to langerhans cells Grant 9,315,580 - Banchereau , et al. April 19, 2	2016-04-19
Antigen Presenting Cell Targeted Cancer Vaccines App 20160022792 - Zurawski; Gerard ; et al.	2016-01-28
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 9,234,040 - Zurawski , et al. January 12, 2	2016-01-12
Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef Grant 9,109,011 - Banchereau , et al. August 18, 2	2015-08-18
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 9,102,730 - Zurawski , et al. August 11, 2	2015-08-11
Fusion proteins comprising antibody and HPV E6 and E7 antigens Grant 9,102,734 - Zurawski , et al. August 11, 2	2015-08-11
Therapeutic Applications Of Activation Of Human Antigen-presenting Cells Through Dectin-1 App 20140322214 - Banchereau; Jacques F. ; et al.	2014-10-30
Anti-cd40 Antibodies And Uses Thereof App 20140234344 - Banchereau; Jacques F. ; et al.	2014-08-21
Agents That Engage Antigen-presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (dc-asgpr) App 20140227268 - Banchereau; Jacques F. ; et al.	2014-08-14
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 8,728,481 - Banchereau , et al. May 20, 2	2014-05-20
Vaccines Based On Targeting Antigen To Dcir Expressed On Antigen-presenting Cells App 20140134168 - Zurawski; Gerard ; et al.	2014-05-15
Activation Of Human Antigen-presenting Cells Through Dendritic Cell Lectin-like Oxidized Ldl Receptor-1 (lox-1) App 20140120617 - BANCHEREAU; JACQUES F. ; et al.	2014-05-01
Vaccines Directed To Langerhans Cells App 20140030264 - Banchereau; Jacques F. ; et al.	2014-01-30
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,586,052 - Zurawski , et al. November 19, 2	2013-11-19
Vaccines Based On Targeting Antigen To Dcir Expressed On Antigen-presenting Cells App 20130295120 - Zurawski; Gerard ; et al.	2013-11-07
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1) Grant 8,481,314 - Banchereau , et al. July 9, 2	2013-07-09
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,449,888 - Zurawski , et al. May 28, 2	2013-05-28
Self-Assembled Bead-Based Multiplexed Assay For Antigen-Specific Antibodies App 20130053271 - Zurawski; Gerard ; et al.	2013-02-28
Immunoglobulin-like Transcript (ilt) Receptors As Cd8 Antagonists App 20120315269 - Klechevsky; Eynav ; et al.	2012-12-13
Agents that Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR) App 20120282281 - Banchereau; Jacques F. ; et al.	2012-11-08
Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells App 20120237513 - Zurawski; Gerard ; et al.	2012-09-20
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) Grant 8,236,934 - Banchereau , et al. August 7, 2	2012-08-07
Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells App 20120121592 - Oh; SangKon ; et al.	2012-05-17
Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells App 20120004643 - Zurawski; Gerard ; et al.	2012-01-05
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Grant 8,057,798 - Zurawski , et al. November 15, 2	2011-11-15
Dendritic Cell Immunoreceptors (dcir)-mediated Crosspriming Of Human Cd8+ T Cells App 20110274653 - Banchereau; Jacques F. ; et al.	2011-11-10
Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor Grant 7,999,078 - Adema , et al. August 16, 2	2011-08-16
Vaccines Directed To Langerhans Cells App 20110081343 - Banchereau; Jacques F. ; et al.	2011-04-07
Anti-cd40 Antibodies And Uses Thereof App 20100239575 - Banchereau; Jacques F. ; et al.	2010-09-23
Activation of Human Antigen-Presenting Cells Through Dendritic Cell Lectin-Like Oxidized LDL Receptor-1 (LOX-1) App 20080267984 - Banchereau; Jacques F. ; et al.	2008-10-30
Activation of Human Antigen-Presenting Cells Through CLEC-6 App 20080254047 - Banchereau; Jacques F. ; et al.	2008-10-16
Therapeutic Applications of Activation of Human Antigen-Presenting Cells Through Dectin-1 App 20080233140 - Banchereau; Jacques F. ; et al.	2008-09-25
Agents That Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR) App 20080206262 - Banchereau; Jacques F. ; et al.	2008-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.